Biodegradable gemcitabine-loaded microdevice with sustained local drug delivery and improved tumor recurrence inhibition abilities for postoperative pancreatic tumor treatment

• Những tác giả chính: Xiangming Kong (Tác giả), Miao Feng (Tác giả), Lihuang Wu (Tác giả), Yiyan He (Tác giả), Hongli Mao (Tác giả), Zhongwei Gu (Tác giả)
• Định dạng: Sách
• Được phát hành: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Những chủ đề: article
• Truy cập trực tuyến: Connect to this object online.

At present, the 10-year survival rate of patients with pancreatic cancer is still less than 4%, mainly due to the high cancer recurrence rate caused by incomplete surgery and lack of effective postoperative adjuvant treatment. Systemic chemotherapy remains the only choice for patients after surgery;...